ACTA1 and pulmonary fibrosis: To examine in vivo anti-fibrotic effects of TM treatment in our large animal model of bleomycin-induced pulmonary fibrosis, we assessed histopathology and collagen deposition in the parenchyma of differentially treated lung tissue segments as well as the expression of αSMA by immunohistochemistry (Figures 7–9).